Harvia Oyj
5.2.2026 14:00:00 CET | Globenewswire | Press release
Harvia will publish its Financial Statements Bulletin 2025 on Thursday, 12 February 2026 at around 9:00 a.m. EET
Harvia will publish its Financial Statements Bulletin 2025 on Thursday, 12 February 2026 at around 9:00 a.m. EET
Harvia Plc press release 5 February 2026 at 3:00 p.m. EET
Harvia will publish its Financial Statements Bulletin 2025 on Thursday, 12 February 2026 at around 09:00 a.m. Finnish time. The stock exchange release and the presentation material will be available after publishing at https://harviagroup.com/reports-and-presentations/.
Harvia will hold a webcast for analysts, investors and media on 12 February 2026 at 11:00 a.m. EET. The conference will be held in English. Harvia’s CEO Matias Järnefelt and CFO Ari Vesterinen will host the event. The webcast can be followed at https://harvia.events.inderes.com/q4-2025.
A recording of the webcast will be available after the event on the company’s website https://harviagroup.com/reports-and-presentations/.
HARVIA PLC
For further information, please contact:
CFO Ari Vesterinen, ari.vesterinen@harvia.com, tel. +358 40 5050 440
Harvia is one of the leading companies operating in the sauna market globally, as measured by revenue. Harvia’s brands and product portfolio are well known in the market, and the company’s comprehensive product portfolio strives to meet the needs of the international sauna market of both private and professional customers.
Harvia’s revenue totaled EUR 175.2 million in 2024. Harvia Group employs approximately 700 professionals in Finland, United States, Germany, Romania, China and Hong Kong, Austria, Italy, and Sweden. The company is headquartered in Muurame, Finland, adjacent to its largest sauna and sauna component manufacturing facility.
Read more: https://harviagroup.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Royal Philips24.8.2026 23:04:56 CEST | Press release
Philips prices EU green bond for EUR 650M
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
Lakefront Receives Transparency Notification from Bank of America
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Cosmos Health Inc.24.8.2026 21:40:00 CEST | Press release
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Kitron ASA24.8.2026 17:07:52 CEST | Press release
Kitron revises full-year 2026 outlook upwards
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom